ILK and SHP2 expression identify a poor prognostic cohort of EGFR-mutant lung cancer

Carminia Maria Della Corte; Carl Michael Gay; Lauren Averett Byers; Floriana Morgillo

doi:10.1016/j.ebiom.2018.12.008

ILK and SHP2 expression identify a poor prognostic cohort of EGFR-mutant lung cancer

Carminia Maria Della Corte, Carl Michael Gay, Lauren Averett Byers, Floriana Morgillo

Thoracic Head & Neck Medical Oncology

Research output: Contribution to journal › Comment/debate › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	5-6
Number of pages	2
Journal	EBioMedicine
Volume	39
DOIs	https://doi.org/10.1016/j.ebiom.2018.12.008
State	Published - Jan 2019

ASJC Scopus subject areas

General Biochemistry, Genetics and Molecular Biology

Access to Document

10.1016/j.ebiom.2018.12.008

Cite this

@article{9be8eebcc3c14013b8ef7c800fd83601,

title = "ILK and SHP2 expression identify a poor prognostic cohort of EGFR-mutant lung cancer",

author = "{Della Corte}, {Carminia Maria} and Gay, {Carl Michael} and Byers, {Lauren Averett} and Floriana Morgillo",

note = "Funding Information: FM has participated to advisory Boards for MSD and Lilly and has institutional research grants from AstraZeneca. Funding Information: LB has done consulting for GenMab and has research support from GenMab and from Tolero Pharmaceuticals. ",

year = "2019",

month = jan,

doi = "10.1016/j.ebiom.2018.12.008",

language = "English (US)",

volume = "39",

pages = "5--6",

journal = "EBioMedicine",

issn = "2352-3964",

publisher = "Elsevier BV",

}

TY - JOUR

T1 - ILK and SHP2 expression identify a poor prognostic cohort of EGFR-mutant lung cancer

AU - Della Corte, Carminia Maria

AU - Gay, Carl Michael

AU - Byers, Lauren Averett

AU - Morgillo, Floriana

N1 - Funding Information: FM has participated to advisory Boards for MSD and Lilly and has institutional research grants from AstraZeneca. Funding Information: LB has done consulting for GenMab and has research support from GenMab and from Tolero Pharmaceuticals.

PY - 2019/1

Y1 - 2019/1

UR - http://www.scopus.com/inward/record.url?scp=85058417764&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058417764&partnerID=8YFLogxK

U2 - 10.1016/j.ebiom.2018.12.008

DO - 10.1016/j.ebiom.2018.12.008

M3 - Comment/debate

C2 - 30553753

AN - SCOPUS:85058417764

SN - 2352-3964

VL - 39

SP - 5

EP - 6

JO - EBioMedicine

JF - EBioMedicine

ER -

ILK and SHP2 expression identify a poor prognostic cohort of EGFR-mutant lung cancer

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this